Coronary flow reserve from mouse to man - From mechanistic understanding to future interventions

Journal of Cardiovascular Translational Research

Volumn 6, Issue 5, 2013, Pages 715-728

  Gan, Li Ming ^a,b   Wikström, Johannes ^b   Fritsche Danielson, Regina ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Cardiac catheterization; Cardiovascular events; Color Doppler; Coronary flow reserve; CT; Ischemia; Ischemic myocardium; Microvascular function; MRI; PET; Risk stratification; Systemic inflammation; Translational medicine; Transthoracic echocardiography

Indexed keywords

ALLOPURINOL; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN INHIBITOR; ARGINASE INHIBITOR; ATORVASTATIN; ATRELEUTON; ENALAPRIL; ENZYME INHIBITOR; EPLERENONE; FENOFIBRATE; FLUINDOSTATIN; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; ISOFLURANE; LISINOPRIL; LOSARTAN; NIFEDIPINE; PERINDOPRIL; PERINDOPRILAT; PLACEBO; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TELMISARTAN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ALBUMINURIA; ANGINA PECTORIS; APHERESIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VISCOSITY; CAPILLARY DENSITY; CARDIOVASCULAR MORTALITY; CONGESTIVE CARDIOMYOPATHY; CONTRAST CT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; CORONARY HEMODYNAMICS; DIABETES MELLITUS; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; LOW DRUG DOSE; MICROVASCULAR ANGINA PECTORIS; MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEIOTROPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; RHEUMATOID ARTHRITIS; SINGLE DRUG DOSE; THERMODILUTION; TRANSLATIONAL RESEARCH; TRANSTHORACIC COLOR DOPPLER ECHOCARDIOGRAPHY;

ANIMALS; CARDIOVASCULAR AGENTS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HEMODYNAMICS; HUMANS; MICE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84885571936     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-013-9497-5     Document Type: Article

References (103)

1. de Fatima Marinho de Souza, M., Gawryszewski, V. P., Orduñez, P., Sanhueza, A., & Espinal, M. A. (2012). Cardiovascular disease mortality in the Americas: current trends and disparities. Heart, 16(98), 1207-1212.
2. Gersh, B. J., Sliwa, K., Mayosi, B. M., & Yusuf, S. (2010). Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. European Heart Journal, 31(6), 642-648.
3. Dorbala, S., Di Carli, M. F., Beanlands, R. S., Merhige, M. E., Williams, B. A., Veledar, E., et al. (2013). Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. Journal of the American College of Cardiology, 61(2), 176-184.
4. Zellweger, M. J., Hachamovitch, R., Kang, X., Hayes, S. W., Friedman, J. D., Germano, G., et al. (2009). Threshold, incidence, and predictors of prognostically high-risk silent ischemia in asymptomatic patients without prior diagnosis of coronary artery disease. Journal of Nuclear Cardiology, 16(2), 193-200.
5. Kannel, W. B., & Thomas, H. E., Jr. (1982). Sudden coronary death: the Framingham Study. Annuals of the New York Academy of Science, 382, 3-21.
6. Reichenbach, D. D., Moss, N. S., & Meyer, E. (1977). Pathology of the heart in sudden cardiac death. The American Journal of Cardiology, 39(6), 865-872.
7. Spaulding, C. M., Joly, L. M., Rosenberg, A., Monchi, M., Weber, S. N., Dhainaut, J. F., et al. (1997). Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. The New England Journal of Medicine, 336(23), 1629-1633.
8. De Bruyne, B., Pijls, N. H., Kalesan, B., Barbato, E., Tonino, P. A., Piroth, Z., et al. (2012). Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. The New England Journal of Medicine, 367(11), 991-1001.
9. Virchow, R. (1856). Thrombose und Embolie. Gefässentzündung und septische Infektion. Gesammelte Abhandlungen zur wissenschaftlichen Medicin (in German). Frankfurt am Main: Von Meidinger & Sohn. pp. 219-732. Matzdorff AC, Bell WR (1998). Thrombosis and Embolie (1846-1856).
10. Lowe, G. D. (2003). Virchow's triad revisited: abnormal flow. Pathophysiology of Haemostasis and Thrombosis, 33(5-6), 455-457.
11. Klabunde, R.E. (2011). Cardiovascular Physiology Concepts, Second Edition. Lippincott Williams & Wilkins, Philadelphia
12. Gould, K. L., Kirkeeide, R. L., & Buchi, M. (1990). Coronary flow reserve as a measure of stenosis severity. Journal of the American College of Cardiology, 15, 459-474.
13. Westerhof, N., Boer, C., Lamberts, R. R., & Sipkema, P. (2006). Crosstalk between cardiac muscle and coronary vasculature. Physiological Reviews, 86, 1263-1308.
14. Gould, K. L., Lipscomb, K., & Hamilton, G. W. (1974). Physiological basis for assessing critical coronary stenosis: instantaneous flow response and regional distribution during coronary hyperaemia as measures of coronary flow reserve. The American Journal of Cardiology, 33, 87-94.
15. Johnson, N. P., & Gould, K. L. (2012). Integrating noninvasive absolute flow, coronary flow reserve, and ischemic thresholds into a comprehensive map of physiological severity. Journal of the American College of Cardiology: Cardiovascular Imaging, 5(4), 430-440.
16. Erdogan, D., Yucel, H., Uysal, B.A., Ersoy, I.H., Icli, A., Akcay, S. et al. (2013). Effects of prediabetes and diabetes on left ventricular and coronary microvascular functions. Metabolism. doi: 10.1016/j.metabol.2013.02.011
17. Dhawan, S. S., Corban, M. T., Nanjundappa, R. A., Eshtehardi, P., McDaniel, M. C., Kwarteng, C. A., et al. (2012). Coronary microvascular dysfunction is associated with higher frequency of thin-cap fibroatheroma. Atherosclerosis, 223(2), 384-388.
18. Johnson, N. P., Kirkeeide, R. L., & Gould, K. L. (2012). Is discordance of coronary flow reserve and fractional flow reserve due to methodology or clinically relevant coronary pathophysiology? Journal of the American College of Cardiology: Cardiovascular Imaging, 5(2), 193-202.
19. Aarnoudse, W. H., Botman, K. J., & Pijls, N. H. (2003). False-negative myocardial scintigraphy in balanced three-vessel disease, revealed by coronary pressure measurement. International Journal of Cardiovascular Interventions, 5(2), 67-71.
20. Aarnoudse, W., Van't Veer, M., Pijls, N. H., Ter Woorst, J., Vercauteren, S., Tonino, P., et al. (2007). Direct volumetric blood flow measurement in coronary arteries by thermodilution. Journal of the American College of Cardiology, 50(24), 2294-2304.
21. Doucette, J. W., Corl, P. D., Payne, H. M., Flynn, A. E., Goto, M., Nassi, M., et al. (1992). Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation, 85, 1899-1911.
22. Siebes, M., Verhoeff, B. J., Meuwissen, M., de Winter, R. J., Spaan, J. A., & Piek, J. J. (2004). Single-wire pressure and flow velocity measurement to quantify coronary stenosis hemodynamics and effects of percutaneous interventions. Circulation, 109(6), 756-762.
23. Bergmann, S. R., Herrero, P., Markham, J., Weinheimer, C. J., & Walsh, M. N. (1989). Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. Journal of the American College of Cardiology, 14, 639-652.
24. Gould, K. L., Goldstein, R. A., Mullani, N. A., et al. (1986). Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator produced rubidium-82. Journal of the American College of Cardiology, 7, 775-789.
25. Kajander, S., Joutsiniemi, E., Saraste, M., Pietilä, M., Ukkonen, H., & Saraste, A. (2010). Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation, 122(6), 603-613.
26. Choo, K.S., Hwangbo, L., Kim, J.H., Park, Y.H., Kim, J.S., Kim, J. (2013). Adenosine-stress low-dose single-scan CT myocardial perfusion imaging using a 128-slice dual-source CT: a comparison with fractional flow reserve. Acta Radiologica. DOI: 10.1177/0284185113475440
27. Christian, T. F., Rettmann, D. W., Aletras, A. H., Liao, S. L., Taylor, J. L., & Balaban, R. S. (2004). Absolute myocardial perfusion in canines measured by using dual-bolus first-pass MR imaging. Radiology, 232, 677-684.
28. Ay, T., Havaux, X., Van Camp, G., Campanelli, B., Gisellu, G., Pasquet, A., et al. (2001). Destruction of contrast microbubbles by ultrasound: effects on myocardial function, coronary perfusion pressure, and microvascular integrity. Circulation, 104, 461-466.
29. Hozumi, T., Yoshida, K., Ogata, Y., Akasaka, T., Asami, Y., Takagi, T., et al. (1998). Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography. Circulation, 97(16), 1557-1562.
30. Lethen, H. P., Tries, H., Kersting, S., & Lambertz, H. (2003). Validation of noninvasive assessment of coronary flow velocity reserve in the right coronary artery. A comparison of transthoracic echocardiographic results with intracoronary Doppler flow wire measurements. European Heart Journal, 24(17), 1567-1575.
31. Murata, E., Hozumi, T., Matsumura, Y., Fujimoto, K., Sugioka, K., & Takemoto, Y. (2006). Coronary flow velocity reserve measurement in three major coronary arteries using transthoracic Doppler echocardiography. Echocardiography, 23(4), 279-286.
32. Takeuchi, M., Lodato, J. A., Furlong, K. T., Lang, R. M., & Yoshikawa, J. (2005). Feasibility of measuring coronary flow velocity and reserve in the left anterior descending coronary artery by transthoracic Doppler echocardiography in a relatively obese American population. Echocardiography, 22(3), 225-232.
33. Cortigiani, L., Rigo, F., Gherardi, S., Bovenzi, F., Molinaro, S., & Picano, E. (2012). Coronary flow reserve during dipyridamole stress echocardiography predicts mortality. Journal of the American College of Cardiology: Cardiovascular Imaging, 5(11), 1079-1085.
34. Wittfeldt, A., Emanuelsson, H., Brandrup-Wognsen, G., van Giezen, J. J., Jonasson, J., Nylander, S., et al. (2013). Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans. Journal of the American College of Cardiology, 61(7), 723-727.
35. Canetti, M., Akhter, M. W., Lerman, A., Karaalp, I. S., Zell, J. A., & Singh, H. (2003). Evaluation of myocardial blood flow reserve in patients with chronic congestive heart failure due to idiopathic dilated cardiomyopathy. The American Journal of Cardiology, 92, 1245-1249.
36. Akasaka, T., Yoshida, K., Hozumi, T., Takagi, T., Kaji, S., Kawamoto, T., et al. (1997). Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus. Journal of the American College of Cardiology, 30, 935-941.
37. Tsagalou, E. P., Anastasiou-Nana, M., Agapitos, E., Gika, A., Drakos, S. G., Terrovitis, J. V., et al. (2008). Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology, 52(17), 1391-1398.
38. Tasaki, H. (2003). Low-density lipoprotein apheresis in the prevention of recurrent coronary heart disease: a review. Thererapeutic Apheresis and Dialysis, 7(4), 408-412.
39. Jeong, H. S., Hong, S. J., Park, J. H., Kim, J. H., Choi, S. C., Ahn, C. M., et al. (2012). Correlation between circulating angiogenic cell mobilizations and recovery of coronary flow reserve in patients with acute myocardial infarction. Circulation Journal, 76(5), 1213-1221.
40. Takahashi, T., Hiasa, Y., Ohara, Y., Miyazaki, S., Ogura, R., Miyajima, H., et al. (2007). Relation between neutrophil counts on admission, microvascular injury, and left ventricular functional recovery in patients with an anterior wall first acute myocardial infarction treated with primary coronary angioplasty. The American Journal of Cardiology, 100(1), 35-40.
41. Sarwar, N., Butterworth, A. S., Freitag, D. F., Gregson, J., Willeit, P., & Gorman, D. N. (2012). Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lance, 379(9822), 1205-1213.
42. Vaccarino, V., Khan, D., Votaw, J., Faber, T., Veledar, E., & Jones, D. P. (2011). Inflammation is related to coronary flow reserve detected by positron emission tomography in asymptomatic male twins. Journal of the American College of Cardiology, 57(11), 1271-1279.
43. Bonetti, P. O., Lerman, L. O., & Lerman, A. (2003). Endothelial dysfunction: a marker of atherosclerotic risk. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 168-175.
44. Park, C. S., Youn, H. J., Kim, J. H., Cho, E. J., Jung, H. O., & Jeon, H. K. (2006). Relation between peripheral vascular endothelial function and coronary flow reserve in patients with chest pain and normal coronary angiogram. International Journal of Cardiology, 113(1), 118-120.
45. Hägg, U., Wandt, B., Bergström, G., Volkmann, R., & Gan, L. M. (2005). Physical exercise capacity is associated with coronary and peripheral vascular function in healthy young adults. American Journal of Physiology - Heart and Circulatory Physiology, 289(4), H1627-H1634.
46. Buus, N. H., Bøttcher, M., Hermansen, F., Sander, M., Nielsen, T. T., & Mulvany, M. J. (2001). Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation, 104(19), 2305-2310.
47. Albertal, M., Voskuil, M., Piek, J. J., de Bruyne, B., Van Langenhove, G., Kay, P. I., et al. (2002). Doppler endpoints balloon angioplasty trial Europe (DEBATE) II study group. Coronary flow velocity reserve after percutaneous interventions is predictive of periprocedural outcome. Circulation, 105(13), 1573-1578.
48. Murthy, V. L., Naya, M., Foster, C. R., Hainer, J., Gaber, M., Di Carli, G., et al. (2011). Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation, 124(20), 2215-2224.
49. Murthy, V. L., Naya, M., Foster, C. R., Gaber, M., Hainer, J., Klein, J., et al. (2012). Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation, 126(15), 1858-1868.
50. Rigo, F., Gherardi, S., Galderisi, M., Pratali, L., Cortigiani, L., & Sicari, R. (2006). The prognostic impact of coronary flow-reserve assessed by Doppler echocardiography in non-ischaemic dilated cardiomyopathy. European Heart Journal, 27(11), 1319-1323.
51. Meimoun, P., Boulanger, J., Luycx-Bore, A., Zemir, H., Elmkies, F., Malaquin, D., et al. (2010). Non-invasive coronary flow reserve after successful primary angioplasty for acute anterior myocardial infarction is an independent predictor of left ventricular adverse remodelling. European Journal of Echocardiography, 11(8), 711-718.
52. Tona, F., Caforio, A. L., Montisci, R., Gambino, A., Angelini, A., Ruscazio, M., et al. (2006). Coronary flow velocity pattern and coronary flow reserve by contrast-enhanced transthoracic echocardiography predict long-term outcome in heart transplantation. Circulation, 114(1 Suppl), I49-I55.
53. Fukui, T., Watanabe, H., Aikawa, M., Tsunoda, Y., Tabata, M., Takanashi, S., et al. (2011). Assessment of coronary flow velocity reserve by transthoracic Doppler echocardiography before and after coronary artery bypass grafting. The American Journal of Cardiology, 107(9), 1324-1328.
54. Hinoi, T., Matsuo, S., Tadehara, F., Tsujiyama, S., & Yamakido, M. (2005). Acute effect of atorvastatin on coronary circulation measured by transthoracic Doppler echocardiography in patients without coronary artery disease by angiography. The American Journal of Cardiology, 96(1), 89-91.
55. Fujimoto, K., Hozumi, T., Watanabe, H., Shimada, K., Takeuchi, M., Sakanoue, Y., et al. (2004). Effect of fluvastatin therapy on coronary flow reserve in patients with hypercholesterolemia. The American Journal of Cardiology, 93(11), 1419-1421.
56. Hong, S. J., Choi, S. C., Kim, J. S., Shim, W. J., Park, S. M., Ahn, C. M., et al. (2010). Low-dose versus moderate-dose atorvastatin after acute myocardial infarction: 8-month effects on coronary flow reserve and angiogenic cell mobilisation. Heart, 96(10), 756-764.
57. Caliskan, M., Erdogan, D., Gullu, H., Topcu, S., Ciftci, O., Yildirir, A., et al. (2007). Effects of Atorvastatin on coronary flow reserve in patients with slow coronary flow reserve. Clinical Cardiology, 30(9), 475-479.
58. Hinoi, T., Tomohiro, Y., Kajiwara, S., Matsuo, S., Fujimoto, Y., Yamamoto, S., et al. (2008). Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy. Hypertension Research, 31(4), 615-622.
59. Motz, W., & Strauer, B. E. (1996). Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension, 27(5), 103-108.
60. Schwartzkopff, B., Brehm, M., Mundhenke, M., & Strauer, B. (2000). Repair of coronary arterioles after treatment with peridonpril in hypertensive heart disease. Hypertension, 36(2), 220-225.
61. Akinboboye, O. O., Chou, R. L., & Bergmann, S. R. (2002). Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonist: a comparision of lisinopril and losartan. Journal of the American College of Cardiology, 40(4), 703-709.
62. Joffe, H. V., Kwong, R. Y., Gerhard-Herman, M. D., Rice, C., Feldman, K., & Adler, G. K. (2007). Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus. The Journal of Clinical Endocrinology and Metabolism, 92(7), 2552-2558.
63. Hesse, B., Meyer, C., Nielsen, F. S., Sato, A., Hove, J. D., Holm, S., et al. (2004). Myocardial perfusion in type 2 diabetes with left ventricular hypertrophy: normalisation by acute angiotensin-converting enzyme inhibition. European Journal of Nuclear Medicine and Molecular Imaging, 31(3), 362-368.
64. Wang, G., He, L., Liu, J., Yu, J., Feng, X., Li, F., et al. (2013). Coronary flow velocity reserve is improved by PPAR-α Agonist fenofibrate in patients with hypertriglyceridemia. Cardiovascular Therapeutics, 31(3), 161-167.
65. Ikonomidis, I., Lekakis, J. P., Nikolaou, M., Paraskevaidis, I., Andreadou, I., Kaplanoglou, T., et al. (2008). Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation, 117(20), 2662-2669.
66. Erdeogan, D., Tayyar, S., Uysal, B. A., Icli, A., Karabacak, M., Ozaydin, M., et al. (2012). Effects of alopurinol on coronary microvascular and left ventricular function in patients with idiopathic dilated cardiomyopathy. Canadian Journal of Cardiology, 28(6), 721-727.
67. Marzilli, M., Merz, C. N., Boden, W. E., Bonow, R. O., Capozza, P. G., Chilian, W. M., et al. (2012). Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! Journal of the American College of Cardiology, 60(11), 951-956.
68. Sen, N., Afsar, B., Ozcan, F., Buyukkaya, E., Isleyen, A., Akcay, A. B., et al. (2013). The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Atherosclerosis, 228(1), 203-210.
69. Ohba, K., Sugiyama, S., Sumida, H., Nozaki, T., Matsubara, J., Matsuzawa, Y., et al. (2012). Microvascular coronary artery spasm presents distinctive clinical features with endothelial dysfunction as nonobstructive coronary artery disease. Journal of the American Heart Association, epub ahead of print.
70. Herrmann, J., Kaski, J. C., & Lerman, A. (2012). Coronary microvascular dysfunction in the clinical setting: from mystery to reality. European Heart Journal, 33(22), 2771-2782b.
71. Gan, L. M., Wikström, J., Bergström, G., & Wandt, B. (2004). Non-invasive imaging of coronary arteries in living mice using high-resolution echocardiography. Scandinavian Cardiovascular Journal, 38(2), 121-126.
72. Wikström, J., Grönros, J., Bergström, G., & Gan, L. M. (2005). Functional and morphologic imaging of coronary atherosclerosis in living mice using high-resolution color doppler echocardiography and ultrasound biomicroscopy. Journal of the American College of Cardiology, 46(4), 720-727.
73. Saraste, A., Kyto, V., Saraste, M., Vuorinen, T., Hartiala, J., & Saukko, P. (2006). Coronary flow reserve and heart failure in experimental coxsackie virus myocarditis. A transthoracic Doppler echocardiography study. American Journal of Physiology - Heart and Circulatory Physiology, 291, H871-H875.
74. Wikström, J., Grönros, J., & Gan, L. M. (2008). Adenosine induces dilation of epicardial coronary arteries in mice - relationship between coronary flow velocity reserve and coronary flow reserve in vivo using transthoracic echocardiography. Ultrasound in Medicine and Biology, 34(7), 1053-1062.
75. Grönros, J., Wikström, J., Hägg, U., Wandt, B., & Gan, L. M. (2006). Proximal to middle left coronary artery flow velocity ratio, as assessed using color Doppler echocardiography, predicts coronary artery atherosclerosis in mice. Arteriosclererosis Thrombosis and Vascular Biology, 26, 1126-1131.
76. Croteau, E., Benard, F., Bentourkia, M. H., Rousseau, J., Paquette, M., & Lecomte, R. (2004). Quantitative myocardial perfusion and coronary reserve in rats with 13N-ammonia and small animal PET:impact of anesthesia and pharmacologic stress agents. Journal of Nuclear Medicine, 45, 1924-1930.
77. Hartley, C. J., Reddy, A. K., Madala, S., Michael, L. H., Entman, M. L., & Taffet, G. E. (2007). Effects of isofluorane on coronary blood flow velocity in young, old and apoE(-/-) mice measured by Doppler ultrasound. Ultrasound in Medicine and Biology, 33(4), 512-521.
78. Saraste, M., Kokskenvuo, J., Knuuti, J., Toikka, J., Laine, H., Niemi, P., et al. (2001). Coronary flow reserve: measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clinical Physiology, 21(1), 114-122.
79. Hägg, U., Grönros, J., Wikström, J., Jonsdottir, I. H., Bergström, G., & Gan, L. M. (2005). Voluntary physical exercise and coronary flow velocity reserve: a transthoracic colour Doppler echocardiography study in spontaneously hypertensive rats. Clinical Science, 109(3), 325-334.
80. Hägg, U., Andersson, I., Naylor, A. S., Grönros, J., Jonsdottir, I. H., Bergström, G., et al. (2004). Voluntary physical exercise-induced vascular effects in spontaneously hypertensive rats. Clinical Science, 107(6), 571-581.
81. Ballantyne, C. M., Raichlen, J. S., Nicholls, S. J., Erbel, R., Tardif, J. C., Brener, S. J., et al. (2008). Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Circulation, 117(19), 2458-2466.
82. Blum, A., & Shamburek, R. (2009). The pleiotropic effects of statin on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis, 203(2), 325-330.
83. Ross, S. D., Allen, I. E., Connelly, J. E., Korenblat, B. M., Smith, M. E., Bishop, D., et al. (1999). Clinical outcomes in statin treatment trials: a meta-analysis. Archives of Internal Medicine, 159(15), 1793-1802.
84. Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Jr., Kastelein, J. J., et al. (2008). Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. The New England Journal of Medicine, 359(21), 2195-2207.
85. de Haan, W., van der Hoogt, C. C., Westerterp, M., Hoekstra, M., Dallinga-Thie, G. M., Princen, H. M., et al. (2008). Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden CETP mice. Atherosclerosis, 197(1), 57-63.
86. van de Poll, S. W., Delsing, D. J., Jukema, J. W., Princen, H. M., Havekes, L. M., Puppels, G. J., et al. (2003). Effects of amlodipine, atorvastatin and combination of both on advanced atherosclerotic plaque in APOE*3-Leiden transgenic mice. Journal of Molecular and Cellular Cardiology, 35(1), 109-118.
87. Kleemann, R., Princen, H. M., Emeis, J. J., Jukema, J. W., Fontijn, R. D., Horrevoets, A. J., et al. (2003). Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin. Circulation, 108(11), 1368-1374.
88. Grönros, J., Wikström, J., Brandt-Eliasson, U., Forsberg, G. B., Behrendt, M., & Hansson, G. M. (2008). Effect of Rosuvastatin on atherosclerosis and cardiovascular function in an ApoE-knockout mouse model of atherosclerosis. American Journal of Physiology - Heart and Circulatory Physiology, 295, H2046-H2053.
89. Grönros, J., Jung, C., Lundberg, J. O., Cerrato, R., Ostenson, C. G., & Pernow, J. (2011). Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats. American Journal of Physiology - Heart and Circulatory Physiology, 300(4), H1174-H1181.
90. Saraste, A., Kytö, V., Laitinen, I., Saraste, M., Leppänen, P., Ylä-Herttuala, S., et al. (2008). Severe coronary artery stenoses and reduced coronary flow velocity reserve in atherosclerotic mouse model: Doppler echocardiography validation study. Atherosclerosis, 200(1), 89-94.
91. Katz, P. S., Trask, A. J., Souza-Smith, F. M., Hutchinson, K. R., Galantowicz, M. L., Lord, K. C., et al. (2011). Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness. Basic Research in Cardiology, 106(6), 1123-1134.
92. Hartley, C. J., Reddy, A. K., Michael, L. H., Entman, M. L., Chintalagattu, V., Khakoo, A. Y., et al. (2010). Coronary flow reserve in mice: effects of age, coronary disease, and vascular loading. Conference Proceedings IEEE Engineering in Medicine and Biology Society, 3780-3783.
93. Samuelsson, B. (1983). Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science, 220, 568-575.
94. Helgadottir, A., Manolescu, A., Thorleifsson, G., et al. (2004). The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nature Genetics, 36, 233-239.
95. Qiu, H., Gabrielsen, A., Agardh, H. E., Wan, M., Wetterholm, A., Wong, C. H., et al. (2006). Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proceedings of the National Academy of Sciences, 103(21), 8161-8166.
96. Tardif, J. C., L'allier, P. L., Ibrahim, R., Grégoire, J. C., Nozza, A., Cossette, M., et al. (2010). Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome. Circulation Cardiovascular Imaging, 3(3), 298-307.
97. Jawien, J., Gajda, M., Rudling, M., Mateuszuk, L., Olszanecki, R., Guzik, T. J., et al. (2006). Inhibition of five lipoxygenase activating protein (FLAP) by MK-886 decreases atherosclerosis in apoE/LDLR-double knockout mice. European Journal of Clinical Investigation, 36(3), 141-146.
98. Cao, R. Y., St Amand, T., Gräbner, R., Habenicht, A. J., & Funk, C. D. (2009). Genetic and pharmacological inhibition of the 5-lipoxygenase/leukotriene pathway in atherosclerotic lesion development in ApoE deficient mice. Atherosclerosis, 203(2), 395-400.
99. Collin, M., Rossi, A., Cuzzocrea, S., Patel, N. S., Dipaola, R., Hadley, J., et al. (2004). Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton. Journal of Leukocyte Biology, 76(5), 961-970.
100. Pleiner, J., Mittermayer, F., Schaller, G., MacAllister, R. J., & Wolzt, M. (2002). High doses of vitamin C reverse escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm. Circulation, 106, 1460-1464.
101. Lefebvre, B., Caron, F., Bessard, G., & Stanke-Labesque, F. (2006). Effect of 5-lipoxygenase blockade on blood pressure and acetylcholine-evoked endothelium-dependent contraction in aorta from spontaneously hypertensive rats. Journal of Hypertension, 24, 85-93.
102. Dahlen, S. E., Bjork, J., Hedqvist, P., Arfors, K. E., Hammarström, S., Lindgren, J. A., et al. (1981). Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proceedings of the National Academy of Sciences, 78, 3887-3891.
103. Allen, S., Dashwood, M., Morrison, K., & Yacoub, M. (1998). Differential leukotriene constrictor responses in human atherosclerotic coronary arteries. Circulation, 97, 2406-2413.